120
Participants
Start Date
April 26, 2023
Primary Completion Date
May 14, 2025
Study Completion Date
October 30, 2025
Siplizumab
Weekly siplizumab doses for a total of 12 weeks
Columbia University Medical Center: Naomi Berrie Diabetes Center, New York
Emory University School of Medicine: Emory & Children's Pediatric Research Center, Division of Endocrinology & Diabetes, Atlanta
University of Miami Miller School of Medicine: Diabetes Research Institute, Miami
University of Alabama at Birmingham: Division of Endocrinology, Diabetes and Metabolism, Birmingham
University of Iowa Children's Hospital: Department of Pediatrics, Pediatric Endocrinology and Diabetes, Iowa City
University of Minnesota Medical School: Division of Pediatric Endocrinology and Diabetes, Minneapolis
Children's Mercy Hospitals and Clinics: Section of Pediatric Endocrinology and Diabetes, Kansas City
University of Texas Southwestern Medical Center: Department of Internal Medicine, Division of Endocrinology, Dallas
University of Colorado School of Medicine: Barbara Davis Center for Diabetes, Aurora
UCSF School of Medicine: UCSF Diabetes Clinic, San Francisco
Benaroya Research Institute at Virginia Mason: Diabetes Research Program, Seattle
Joslin Diabetes Center: Joslin Clinic, Boston
National Institute of Allergy and Infectious Diseases (NIAID)
NIH